aid: acerna name: aceRNA Technologies description: >- aceRNA Technologies Co., Ltd. is a Japanese biotechnology venture founded in April 2018 to commercialize the RNA design technology ("RNA Switch") developed in the synthetic RNA biology laboratory of Prof. Hirohide Saito at Kyoto University. An RNA Switch is embedded into a messenger RNA so that expression of the therapeutic transgene is gated by the activity of a specific microRNA inside the cell, letting a treatment act only on the cell type and cell state that is diseased. The company applies the platform across mRNA medicines, cell therapy and gene therapy, co-develops with partners (an agreement with Nitto Denko was announced in December 2021), and closed a JPY 960M Series B in May 2024 led by DCI Partners. It is headquartered at the University of Tokyo Entrepreneur Plaza. aceRNA runs no developer programme and publishes no API reference, OpenAPI or SDK; the only machine-readable surfaces on its domain are the Wix-platform llms.txt and Site MCP endpoint, both captured here. image: https://static.wixstatic.com/media/0bb01f_e4929cb81df449498969dcb40a661968~mv2.png url: https://raw.githubusercontent.com/api-evangelist/acerna/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-source-listing: https://equityzen.com/company/acerna specificationVersion: '0.20' created: '2026-09-06' modified: '2026-09-06' tags: - Company - Biotechnology - Therapeutics - Genetic Medicine - Life Sciences - Pharmaceuticals - Japan - MCP tags_raw: - Company - Biotechnology - Therapeutics - Genetic Medicine - Life Sciences - Pharmaceuticals - Japan - Model Context Protocol apis: - aid: acerna:site-mcp name: aceRNA Technologies Site MCP description: >- A live, anonymously reachable Model Context Protocol endpoint served from aceRNA Technologies' own host and advertised in the site's llms.txt. It is provided by the Wix platform, not built by aceRNA — it exposes generic Wix site tools (business details, in-site search, site API doc search, anonymous visitor-token issuance and a Wix REST API call/execute bridge) over the public content of www.acernatec.com. A tools/list call returns 9 tools with real JSON Schema inputs. There is no aceRNA-authored API behind it. image: https://static.wixstatic.com/media/0bb01f_e4929cb81df449498969dcb40a661968~mv2.png humanURL: https://www.acernatec.com/ baseURL: https://www.acernatec.com/_api/mcp tags: - MCP - Website tags_raw: - Model Context Protocol - Website properties: - type: MCPServer url: mcp/acerna-mcp.yml - type: LLMsTxt url: llms/acerna-llms.txt - type: Authentication url: authentication/acerna-authentication.yml maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io x-enrichment: date: '2026-09-06' status: enriched artifacts_added: 9 pass: local-v3 x-coverage: state: covered reason: covered detail: >- aceRNA Technologies runs no developer programme and publishes no OpenAPI, GraphQL SDL, SDK or webhook surface, but its Wix-hosted site does serve a real llms.txt and a live, anonymously callable Site MCP endpoint at /_api/mcp that returns 9 tools with JSON Schema inputs — both captured verbatim here. evidence: - url: https://www.acernatec.com/llms.txt status: 200 - url: https://www.acernatec.com/_api/mcp status: 200 - url: https://www.acernatec.com/openapi.json status: 400 - url: https://www.acernatec.com/.well-known/agent-card.json status: 400 checked: '2026-09-06' common: - type: Website url: https://www.acernatec.com/ - type: MCPServer url: mcp/acerna-mcp.yml - type: LLMsTxt url: llms/acerna-llms.txt - type: Authentication url: authentication/acerna-authentication.yml - type: Conformance url: conformance/acerna-conformance.yml - type: DomainSecurity url: security/acerna-domain-security.yml - type: Blog url: https://www.acernatec.com/en/news/ - type: Support url: https://www.acernatec.com/en/contact/ - type: PrivacyPolicy url: https://www.acernatec.com/en/privacypolicy/ - type: LinkedIn url: https://www.linkedin.com/company/acerna-technologies